Compare GRFS & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | CHH |
|---|---|---|
| Founded | 1940 | 1939 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.1B |
| IPO Year | N/A | 1997 |
| Metric | GRFS | CHH |
|---|---|---|
| Price | $7.13 | $111.74 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 11 |
| Target Price | $10.15 | ★ $114.30 |
| AVG Volume (30 Days) | ★ 657.9K | 631.3K |
| Earning Date | 07-28-2022 | 04-30-2026 |
| Dividend Yield | ★ 1.80% | 0.98% |
| EPS Growth | N/A | ★ 27.42 |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $1,596,793,000.00 |
| Revenue This Year | $4.49 | $66.74 |
| Revenue Next Year | $6.42 | $0.37 |
| P/E Ratio | ★ $18.67 | $255.20 |
| Revenue Growth | N/A | ★ 0.75 |
| 52 Week Low | $6.96 | $84.04 |
| 52 Week High | $11.14 | $136.45 |
| Indicator | GRFS | CHH |
|---|---|---|
| Relative Strength Index (RSI) | 38.73 | 52.92 |
| Support Level | N/A | $103.40 |
| Resistance Level | $7.73 | $117.24 |
| Average True Range (ATR) | 0.16 | 3.72 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 25.97 | 41.84 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
At year-end 2025, Choice Hotels operated 657,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (27% of the company's total rooms), while Ascend and Cambria (10%) are lifestyle and select-service brands, and WoodSpring (5%) is the company's largest extended-stay brand. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2025.